DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype. - Maurizi G; Mattiucci D; Mariani M; Ciarlantini M; Traini S; Mancini S; Olivieri A; Leoni P; Poloni A (British journal of haematology, 2017)